J&J Innovative Medicine

He may not wear a lab coat, but Johnson & Johnson (that’s his name!) is a member of the family, thanks to a conservation partnership between Xian Janssen and the Shaanxi Academy of Forestry Qinling Mountains Giant Panda Breeding Center. We catch up with the mischievous youngster on the anniversary of his adoption ceremony.

In the lead-up to the recent International AIDS Society Conference on HIV Science in the Netherlands, we sat down with Hanneke Schuitemaker, who’s hard at work on the holy grail of HIV research: a preventive treatment.

In this recap of Johnson & Johnson’s latest earnings report, you can learn how the company’s consumer, pharmaceutical and medical devices businesses performed in the second quarter of 2018.

For International Transgender Day of Visibility, Clark Musto shares his inspiring story—one made possible, in part, due to the support he received at work.

Learn how the company’s consumer, pharmaceutical and medical devices businesses performed in the first quarter of 2018 in this recap of Johnson & Johnson’s latest earnings report.

See how the company’s consumer, pharmaceutical and medical devices businesses performed in 2017 in this breakdown of its latest annual earnings report.

The company has once again been recognized for its commitment to employees, innovation and the health and well-being of people around the world.

As the International AIDS Society Conference on HIV Science kicks off, we’re spotlighting researchers who’ve dedicated their life’s work to tackling the epidemic in groundbreaking ways.

Each year, Johnson & Johnson recognizes a scientist whose work has the potential to transform human health. We caught up with this year’s winner, who has dedicated his career to studying the powers of mitochondrial DNA.

Joaquin Duato, Executive Vice President and Worldwide Chairman, Pharmaceuticals, shares how the transaction will help expand the company’s portfolio of transformational therapies.